Gas chromatography–mass spectrometry (GC–MS) and liquid chromatography–mass spectrometry (LC–MS) reveal lasting brain cholesterol loss after myelin damage.
News|Articles|December 18, 2025
- December 2025
- Volume 21
- Issue 4
Vol 21 No 4 The Column December 2025 Europe Link
Key Takeaways
- Personalized treatment strategies have advanced significantly, improving outcomes for lung cancer brain metastases patients through targeted therapies and immunotherapies.
- Molecular profiling and advanced imaging techniques enable precise treatment planning, enhancing the effectiveness of therapeutic interventions.
Click here to view the European interactive link of The Column November 2025 issue.
Advertisement
Click here to view our interactive European
Articles in this issue
9 months ago
A Look to the Future of Chromatography10 months ago
The Essential Skills Needed for Leading a Lab10 months ago
The Next Leap in Pharmaceutical Informatics Strategy10 months ago
The Scientist’s Value in the Age of Automation10 months ago
Event Preview: SFC/SFE Japan 2026Advertisement
Related to this article
Metrohm USA's IONIC Titrator offers cloud access and a 10-inch touchscreen.
Chromatography and spectrometry were used in tandem to reveal how ultrasound boosts chicken soup flavor compounds.
Kinjal Bhatt would expose early-career scientists to the field sooner, while Ina Varfaj says a broken chromatography column taught her failure is normal.
Epitope detection chromatography (EDC) links pea galactan levels to stem elongation.
Perfusion chromatography offers improved separation of oligonucleotide biotherapeutics at ultra-high velocities.
Size exclusion chromatography (SEC) plus precipitation improves extracellular vesicle (EV) purity from blood plasma.
Nitish Sharma and Piotr Alvarez compare reverse-phase separations of small molecules vs. peptides, from pI value and hydrophobicity to impurity profiles.
Advertisement
Advertisement